2020-06-10T09:47:05-05:00 2019-12-31 042689883 WOLF & COMPANY PC 99 HIGH STREET 21ST FLOOR BOSTON MA 02110 990 2019-01-01 900133592 ADDGENE INC ADDG 6172259000 490 ARSENAL WAY WATERTOWN MA 02472 MICHAEL LOHNES SENIOR DIRECTOR OF FINANCE 6172259000 2020-06-09 1 HARRY A KALAJIAN JR CPA P00464296 6174399700 2020-06-10 199.167.121.238 2020-06-10 09:15:38 ED P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 3035F85F9C36F92B25132AD5EF9C80758CB5F135 2019 2021-01-29 14:40:06Z JOANNE KAMENS 490 ARSENAL WAY WATERTOWN MA 02472 19654855 0 X WWW.ADDGENE.ORG X 2004 MA ADDGENE, INC. PROVIDES RESEARCH SUPPORT SERVICE DEDICATED TO ARCHIVING AND DISTRIBUTING PLASMIDS THAT APPEAR IN PUBLISHED ARTICLES. BY LINKING PLASMIDS WITH PUBLICATIONS, SCIENTISTS ARE ALWAYS CONNECTED TO DATA GENERATED FROM THE MATERIALS THAT THEY ARE REQUESTING. THE COMPANY'S GOAL IS TO COMPILE A COMPREHENSIVE LIBRARY OF PLASMIDS TO FACILITATE RESEARCH AND DISCOVERY. 12 8 130 11 77 0 10000 115000 16424380 19520406 -177864 19372 1691 77 16258207 19654855 0 0 0 0 7238986 8476034 0 0 0 8060850 10168387 15299836 18644421 958371 1010434 12441448 13861742 1457899 1872389 10983549 11989353 X ADDGENE, INC. PROVIDES RESEARCH SUPPORT SERVICE DEDICATED TO ARCHIVING AND DISTRIBUTING PLASMIDS THAT APPEAR IN PUBLISHED ARTICLES. BY LINKING PLASMIDS WITH PUBLICATIONS, SCIENTISTS ARE ALWAYS CONNECTED TO DATA GENERATED FROM THE MATERIALS THAT THEY ARE REQUESTING. THE COMPANY'S GOAL IS TO COMPILE A COMPREHENSIVE LIBRARY OF PLASMIDS TO FACILITATE RESEARCH AND DISCOVERY. 0 0 14313628 19520406 THE STORAGE AND DISTRIBUTION OF DNA-BASED REAGENTS IN SUPPORT OF SCIENTIFIC RESEARCH. 14313628 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 23 0 1 130 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 12 8 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 MA X MICHAEL LOHNES 6172259000 490 ARSENAL WAY NO100 WATERTOWN MA 02472 DAVID ROOT DIRECTOR 1.00 X 0 0 0 JOANNE NIEWOOD PRESIDENT/EXECUTIVE DIRECTOR 40.00 X X 206644 0 25879 KENNETH FAN TREASURER/DIRECTOR 1.00 X X 0 0 0 MELINA FAN DIR/CHIEF SCIENTIFIC OFFICER 40.00 X X 202122 0 22791 KRISTIN DARBY DIRECTOR 1.00 X 0 0 0 JOANNA BROWNSTEIN DIRECTOR 1.00 X 0 0 0 MICHAEL KOERIS DIRECTOR 1.00 X 0 0 0 DARRELL KOTTON DIRECTOR 1.00 X 0 0 0 KAREN KATZ DIRECTOR 1.00 X 0 0 0 BENJIE CHEN DIRECTOR 1.00 X 0 0 0 CONSTANCE CEPKO DIRECTOR 1.00 X 0 0 0 CARL PARATORE DIRECTOR 1.00 X 0 0 0 JOHN H CHU CLERK 1.00 X 0 0 0 MICHAEL LOHNES SENIOR DIRECTOR OF FINANCE 40.00 X 146168 0 14735 DANIELA BOURGES-WALDEGG CHIEF TECHNOLOGY OFFICER 40.00 X 167248 0 18210 ANDREW BALTUS CHIEF OPERATING OFFICER 40.00 X 163388 0 18836 LIANNA SWANSON SENIOR DIRECTOR OF BIOLOGY 40.00 X 124812 0 25487 HEATHER ZIRKLE SENIOR PRODUCT OWNER 40.00 X 129701 0 2271 ERIC PERKINS DIR. OF PRODUCT DEVELOPMENT 40.00 X 128394 0 4207 MEGHAN REGO ASSOCIATE DIRECTOR OF VIRAL VECTORS 40.00 X 130841 0 19581 SOPHIA CHENG DEVELOPER 40.00 X 123763 0 20570 1523081 0 172567 15 0 1 0 UPS 996 MASSACHUSETTS AVENUE CAMBRIDGE MA 02139 SHIPPING 1928427 LGC LIMITED QUEENS ROAD TEDDINGTON MIDDLESEX UK TW11 0LY CONSULTING SERVICES 436945 VWR INTERNATIONAL LLC PO BOX 640169 PITSBURGH PA 15264 LAB SERVICES 426987 SEQWELL INC 376 HALE STREET BEVERLY MA 01915 TECHNOLOGY SERVICES 282240 NEWTEK MERCHANT SOLUTIONS 744 N 4TH STREET MILWAUKEE WI 53203 CREDIT CARD MERCHANT 210153 8 115000 115000 PLASMID SALES 541700 19520406 19520406 19520406 2988 2988 16384 0 16384 16384 16384 OTHER INCOME 900099 77 77 77 19654855 19520406 77 19372 885570 619899 265671 5780557 4046390 1734167 49584 29578 20006 1197076 714096 482980 563247 394273 168974 25972 2597 23375 34756 34756 549471 316886 232585 185831 174376 11455 337848 116323 221525 223958 111979 111979 2156822 1502477 654345 95286 47643 47643 5968 2984 2984 463021 347266 115755 97878 97878 LAB EXPENSES 3225224 3225224 PRODUCT SHIPPING FEES 2439254 2439254 ORDER MERCHANT CARD FEE 210153 210153 BAD DEBT EXP 98288 98288 18657 12230 6427 18644421 14313628 4330793 0 6071534 6862133 1668595 1650440 1062369 1232978 1253473 1922484 284784 208519 3091345 1158241 1640688 1933104 460005 52084 12441448 13861742 1340877 1389295 117022 483094 1457899 1872389 X 10983549 11989353 10983549 11989353 12441448 13861742 X 1010434 -4631 X X 0 1 X 1 0 X DANA-FARBER CANCER INSTITUTE BOSTON MA RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 764671 62492 702179 1567723 826543 741180 758951 269206 489745 1933104 X 19638471 0 19638471 16384 16384 19654855 18632667 -11753 -11753 18644420 0 18644420 PART X, LINE 2: THE COMPANY IS EXEMPT FROM FEDERAL INCOME TAXES UNDER INTERNAL REVENUE CODE SECTION 501(C)(3) AND THEREFORE HAS MADE NO PROVISION FOR FEDERAL OR STATE INCOME TAXES. THE COMPANY FOLLOWS ACCOUNTING GUIDANCE REGARDING THE RECOGNITION, MEASUREMENT, PRESENTATION, AND DISCLOSURE OF UNCERTAIN TAX POSITIONS IN THE FINANCIAL STATEMENTS. TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN THE COURSE OF PREPARING THE COMPANY'S TAX RETURNS, INCLUDING THE POSITION THAT THE COMPANY QUALIFIES AS A TAX EXEMPT ENTITY, ARE REQUIRED TO BE EVALUATED TO DETERMINE WHETHER THE TAX POSITIONS ARE "MORE-LIKELY-THAN-NOT" TO BE UPHELD UNDER REGULATORY REVIEW. TAX POSITIONS NOT DEEMED TO MEET A MORE-LIKELY-THAN-NOT THRESHOLD WOULD BE DISCLOSED IN THE FINANCIAL STATEMENTS. THERE WERE NO UNCERTAIN TAX POSITIONS THAT REQUIRE DISCLOSURE IN THE FINANCIAL STATEMENTS AS OF DECEMBER 31, 2019 AND 2018. THE COMPANY RECORDS INTEREST AND PENALTIES, IF ANY, AS PART OF INCOME TAX EXPENSE. NO INTEREST OR PENALTIES WERE RECORDED IN 2019 OR 2018. THE COMPANY'S INCOME TAX RETURNS ARE SUBJECT TO REVIEW AND EXAMINATION BY FEDERAL AND STATE TAXING AUTHORITIES. THE COMPANY IS CURRENTLY OPEN TO AUDIT UNDER THE APPLICABLE STATUTES OF LIMITATIONS BY THE INTERNAL REVENUE SERVICE AND STATE TAXING AUTHORITIES FOR THE YEARS ENDED AFTER DECEMBER 31, 2015. PART XI, LINE 4B - OTHER ADJUSTMENTS: ASSET DISPOSAL 16,384. PART XII, LINE 2D - OTHER ADJUSTMENTS: FOREIGN CURRENCY LOSS 4,631. ASSET DISPOSAL -16,384. EUROPE 0 0 PROGRAM SERVICES MARKETING/ADMIN SERVICE 436945 0 0 0 0 0 0 436945 0 436945 0 0 0 0 0 0 PART III ACCOUNTING METHOD: X X X X X 0 0 0 0 0 0 0 0 0 JOANNE NIEWOOD PRESIDENT/EXECUTIVE DIRECTOR 198848 0 7280 0 516 0 5966 0 19913 0 232523 0 0 0 MELINA FAN DIR/CHIEF SCIENTIFIC OFFICER 194722 0 7280 0 120 0 5910 0 16881 0 224913 0 0 0 MICHAEL LOHNES SENIOR DIRECTOR OF FINANCE 138773 0 7280 0 115 0 837 0 13898 0 160903 0 0 0 DANIELA BOURGES-WALDEGG CHIEF TECHNOLOGY OFFICER 159788 0 7280 0 180 0 0 0 18210 0 185458 0 0 0 ANDREW BALTUS CHIEF OPERATING OFFICER 155988 0 7280 0 120 0 4680 0 14156 0 182224 0 0 0 LIANNA SWANSON SENIOR DIRECTOR OF BIOLOGY 117450 0 7280 0 82 0 3755 0 21732 0 150299 0 0 0 MEGHAN REGO ASSOCIATE DIRECTOR OF VIRAL VECTORS 129738 0 1000 0 103 0 837 0 18744 0 150422 0 0 0 COMPENSATION COMMITTEE THE INDEPENDENT BOARD MEMBERS ACT AS THE COMPENSATION COMMITTEE AND HAVE IN PLACE A FORMAL WRITTEN PROCESS TO EVALUATE AND SET THE COMPENSATION OF THE CEO AND OTHER OFFICERS. CHU RING & HAZEL JOHN CHU, PTR OF LAW FIRM 7982 LEGAL FEES 0 HAMILTON BROOK SMITH & REYNOLDS DAVID BROOK, PARTNER 331 LEGAL FEES 0 FORM 990, PART VI, SECTION A, LINE 2 MELINA FAN AND KENNETH FAN ARE SIBLINGS. MELINA FAN AND BENJIE CHEN ARE SPOUSES. FORM 990, PART VI, SECTION B, LINE 11B FORM 990 WAS REVIEWED BY MANAGEMENT ALONG WITH THE AUDITED FINANCIAL STATEMENTS. A FULL COPY OF FORM 990 IS PROVIDED TO ALL BOARD MEMBERS FOR REVIEW PRIOR FILING TO THE IRS. FORM 990, PART VI, SECTION B, LINE 12C ADDGENE, INC. HAS A CONFLICT OF INTEREST POLICY IN PLACE. ALL OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE REQUIRED TO DISCLOSE ANNUALLY ANY INTERESTS THAT COULD GIVE RISE TO CONFLICTS. INQUIRES ARE MADE DURING BOARD OF DIRECTOR MEETINGS. FORM 990, PART VI, SECTION B, LINE 15 ADDGENE, INC.'S INDEPENDENT BOARD MEMBERS REVIEWED AND DETERMINED THE COMPENSATION OF ALL OFFICERS ANNUALLY. FORM 990, PART VI, SECTION C, LINE 19 ADDGENE, INC.'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XI, LINE 9: FOREIGN CURRENCY LOSSES -4,631. FORM 990, PART XII CINE 2C THERE WAS NO CHANGE IN THE OVERSIGHT PROCEES OR SELECTION PROCESS DURING THE TAX YEAR 2019.